Insider Trading & Ownership - Stephenson Pamela

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Stephenson Pamela
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-02-18
Sale
2025-02-20
7:38 pm
Disc Medicine Inc. IRON Stephenson Pamela
Chief Commercial Officer
3,137 $54.58 $171,217 69,529
(Direct)
View
2023-06-14
Sale
2023-06-15
4:30 pm
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
115 $0.3481 $40 147,514
(Direct)
View
2023-01-23
Sale
2023-01-23
5:12 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
102 $43.8 $4,468 42,755
(Direct)
View
2023-01-19
Sale
2023-01-20
4:05 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
1,774 $43.9 $77,886 42,857
(Direct)
View
2022-12-27
Sale(A)
2023-01-09
6:42 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
469 $19.06 $8,940 44,631
(Direct)
View
2022-07-22
Sale(A)
2023-01-09
6:41 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
106 $24.67 $2,615 45,649
(Direct)
View
2022-12-27
Sale
2022-12-27
4:05 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
469 $19.06 $8,940 45,178
(Direct)
View
2022-10-24
Sale
2022-10-25
4:00 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
104 $19.58 $2,036 45,647
(Direct)
View
2022-09-26
Sale
2022-09-27
4:01 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
445 $19.4 $8,635 45,751
(Direct)
View
2022-07-22
Sale
2022-07-25
4:14 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
106 $24.67 $2,615 46,196
(Direct)
View
2022-06-27
Sale
2022-06-28
4:02 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
461 $19.47 $8,976 45,755
(Direct)
View
2022-06-14
Sale
2022-06-16
9:51 pm
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
40 $1.01 $40 62,732
(Direct)
View
2022-04-22
Sale
2022-04-25
4:40 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
103 $32.92 $3,391 46,216
(Direct)
View
2022-03-28
Sale
2022-03-29
4:00 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
454 $30.52 $13,858 46,319
(Direct)
View
2022-01-24
Sale
2022-01-25
4:38 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
416 $24.88 $10,351 46,773
(Direct)
View
2021-12-27
Sale
2021-12-27
4:02 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
474 $23.92 $11,339 25,589
(Direct)
View
2021-09-27
Sale
2021-09-28
4:32 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
451 $32.05 $14,456 26,063
(Direct)
View
2021-06-25
Sale
2021-06-28
4:02 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
471 $36.01 $16,961 26,514
(Direct)
View
2021-03-29
Sale
2021-03-31
7:21 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
422 $34.02 $14,355 26,985
(Direct)
View
2020-12-28
Sale
2020-12-29
4:19 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
460 $39.07 $17,974 21,907
(Direct)
View
2020-09-25
Sale
2020-09-25
5:05 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
451 $33.2 $14,973 22,367
(Direct)
View
2020-06-25
Sale
2020-06-26
5:02 pm
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
397 $30.79 $12,224 22,818
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-02-10
Option Award
2025-02-12
6:48 pm
N/A
2035-02-09
Disc Medicine Inc. IRON Stephenson Pamela
Chief Commercial Officer
36,000 $0 108,666
(Direct)
View
2024-02-26
Option Award
2024-02-27
5:38 pm
N/A
2034-02-25
Disc Medicine Inc. IRON Stephenson Pamela
Chief Commercial Officer
91,666 $0 91,666
(Direct)
View
2023-10-10
Equity Swap
2023-10-11
10:12 am
N/A
N/A
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
75,778 $0 0
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:30 pm
N/A
2033-06-13
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
119,560 $0 147,514
(Direct)
View
2023-03-02
Equity Swap
2023-03-02
4:54 pm
N/A
N/A
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
22,242 $0 0
(Direct)
View
2023-01-19
Option Award(A)
2023-01-27
5:23 pm
N/A
N/A
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
55,000 $0 97,755
(Direct)
View
2023-01-19
Option Award
2023-01-25
8:07 pm
N/A
N/A
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
55,000 $0 97,755
(Direct)
View
2022-06-14
Option Award
2022-06-16
9:51 pm
N/A
2032-06-14
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
57,772 $0 62,732
(Direct)
View
2022-01-18
Option Award
2022-01-20
4:49 pm
N/A
N/A
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
21,600 $0 47,189
(Direct)
View
2021-08-03
Option Award
2021-08-05
5:29 pm
N/A
2031-08-03
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
12,500 $0 12,500
(Direct)
View
2021-01-21
Option Award
2021-01-25
5:34 pm
N/A
2031-01-20
ALBIREO PHARMA INC. ALBO Stephenson Pamela
Chief Commercial Officer
29,200 $0 51,107
(Direct)
View
2020-06-10
Option Award
2020-06-11
5:36 pm
N/A
2030-06-10
Zynerba Pharmaceuticals Inc. ZYNE Stephenson Pamela
Director
15,000 $0 15,000
(Direct)
View
(A) Indicate amendment filing.